Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Beijing Chao Yang Hospital is the lead sponsor of 36 current clinical trials in our China register. 23 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Aspirin and Heparin. The most-studied condition is Sepsis.

ClinicalTrials.gov trials by status

Recruiting2364%
Not yet open38%
Active, closed13%
By invitation925%

Trials by phase

Not applicable1953%
Observational1439%
Phase 438%

Clinical trials sponsored by Beijing Chao Yang Hospital

36 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors NCT06950697 · ClinicalTrials.gov ↗ · Lung Cancer, Venous Thromboembolism, Arterial Thromboembolism	Observational	Recruiting	2019-01	China
Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes NCT06639425 · ClinicalTrials.gov ↗ · Type 2 Diabetes	Not applicable	Recruiting	2024-10	China
Evaluation of Membrane Lung Function in High-altitude Regions NCT06152744 · ClinicalTrials.gov ↗ · Extracorporeal Membrane Oxygenation, Membrane Lung Function, High Altitude	Observational	Recruiting	2023-12	China
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET) NCT04916197 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Phase 4	Recruiting	2024-03	China
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO NCT06062212 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation, Mechanical Power	Observational	Recruiting	2023-10	China
Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer NCT05202314 · ClinicalTrials.gov ↗ · Colorectal Cancer, Neoadjuvant Chemotherapy, Stent	Not applicable	Recruiting	2021-12	China
A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation NCT06676085 · ClinicalTrials.gov ↗ · ECMO Drug: Heparin	Not applicable	Recruiting	2025-05	China
Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases NCT07472738 · ClinicalTrials.gov ↗ · Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Chronic Airway Diseases	Observational	Recruiting	2025-05	China
Exploring the Predictive Value of Electroencephalography Features in Perioperative Neurocognitive Disorders Following Cardiovascular Surgery NCT06692309 · ClinicalTrials.gov ↗ · Cardiovascular Surgery, Perioperative Neurocognitive Disorders	Observational	Recruiting	2023-03	China
Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension NCT06980584 · ClinicalTrials.gov ↗ · Fibrosing Mediastinitis, Pulmonary Hypertension	Not applicable	Recruiting	2025-02	China
A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit NCT02738645 · ClinicalTrials.gov ↗ · Pneumonia	Observational	Recruiting	2016-06	China
Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer NCT04743102 · ClinicalTrials.gov ↗ · Rectal Cancer, Neoadjuvant Therapy, Complete Remission	Not applicable	Recruiting	2021-01	China
Er:YAG Laser and Air Polishing Application in Periodontal Treatment NCT06574802 · ClinicalTrials.gov ↗ · Periodontitis	Not applicable	Recruiting	2024-09	China
The Cohort Study for Asthma in China NCT05937334 · ClinicalTrials.gov ↗ · Asthma, Bronchial	Observational	Recruiting	2023-01	China
Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy NCT07049692 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Not applicable	Recruiting	2026-07	China
IMPACT COPD Cohort (China) NCT07382986 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease (COPD), Multimorbidities	Observational	Recruiting	2026-02	China
Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation NCT07819630 · ClinicalTrials.gov ↗ · Postoperative Pain	Not applicable	Recruiting	2026-10	China
FAPl Imaging Assessment of Revascularization Outcome in Ischemic Heart Failure NCT07657650 · ClinicalTrials.gov ↗ · Ischemic Heart Failure	Observational	Recruiting	2026-04	China
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System NCT07136025 · ClinicalTrials.gov ↗ · Asthma	Not applicable	Recruiting	2025-02	China
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak NCT07209787 · ClinicalTrials.gov ↗ · Rectal Cancer	Phase 4	Recruiting	2025-10	China
Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS NCT07490925 · ClinicalTrials.gov ↗ · ARDS (Moderate or Severe)	Not applicable	Recruiting	2026-03	China
PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study NCT07822737 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Plaque, Photon-Counting Computed Tomography	Observational	Recruiting	2025-01	China
Early PP Monitored by EIT in Patients With ARDS NCT05822869 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome	Not applicable	Recruiting	2023-05	China
Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction（ELASTIC） NCT07563673 · ClinicalTrials.gov ↗ · Cerebral Infarction, Thrombolysis Drug: Aspirin	Phase 4	Not yet open	2026-05	China
Impact of HI-NPPV Vs LI-NPPV on Tolerance Among AECOPD Patients NCT06692023 · ClinicalTrials.gov ↗ · Acute Exacerbation of Chronic Obstructive Pulmonary Disease	Not applicable	Not yet open	2024-12	China
Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes NCT07520305 · ClinicalTrials.gov ↗ · Type 2 Diabetes	Not applicable	Not yet open	2026-04	China
Acute Kidney Injury in Critically Ill Patients NCT07653321 · ClinicalTrials.gov ↗ · Acute Kidney Injury	Observational	By invitation	2026-05	China
The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China NCT03044847 · ClinicalTrials.gov ↗ · Pulmonary Disease, Chronic Obstructive	Observational	By invitation	2016-07	China
Adaptive Blood Purification for the Treatment of Patients With Septic Shock NCT06692036 · ClinicalTrials.gov ↗ · Septic Shock	Not applicable	By invitation	2025-01	China
The Study of ENB With Ultra-thin Cryobiopsy in the Diagnosis of Peripheral Pulmonary Nodules NCT07326072 · ClinicalTrials.gov ↗ · Diagnosis	Not applicable	By invitation	2025-09	China
Comparative Study of Rotational Cryobiopsy Needle and Automated Biopsy Needle in Transthoracic Biopsy Diagnosing Peripheral Pulmonary Lesions NCT07772479 · ClinicalTrials.gov ↗ · Peripheral Pulmonary Lesions (PPLs), Pulmonary Nodules	Not applicable	By invitation	2025-03	China
Immunity in Critical Sepsis NCT07770347 · ClinicalTrials.gov ↗ · Sepsis	Not applicable	By invitation	2026-06	China
Immune Evaluation for Postoperative Sepsis-AKI NCT07811544 · ClinicalTrials.gov ↗ · Sepsis, Acute Kidney Injury	Observational	By invitation	2026-01	China
Sepsis in Critically Ill Patients NCT07707622 · ClinicalTrials.gov ↗ · Sepsis	Observational	By invitation	2026-06	China
Treatable Traits of Severe Asthma NCT06811740 · ClinicalTrials.gov ↗ · Asthma	Not applicable	By invitation	2024-01	China
Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal Reflux NCT06732661 · ClinicalTrials.gov ↗ · Sleeve Gastrectomy, Pre-cardial Fat Pad, Excessive Weight Loss	Not applicable	Active, closed	2024-07	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Beijing Chao Yang Hospital trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Aspirin1 Heparin1

Conditions in Beijing Chao Yang Hospital trials

53 conditions

Sepsis3 Acute Kidney Injury2 Type 2 Diabetes2Extracorporeal Membrane Oxygenation2Acute Ischemic Stroke2 Acute Respiratory Distress Syndrome2 Chronic Obstructive Pulmonary Disease (COPD)2 Rectal Cancer2 Asthma2Pulmonary Disease, Chronic Obstructive1Lung Cancer1 Venous Thromboembolism1Arterial Thromboembolism1Immune Checkpoint Inhibitors (ICIs)1Sleeve Gastrectomy1Pre-cardial Fat Pad1Excessive Weight Loss1Total Weight Loss1Membrane Lung Function1High Altitude1Cerebral Infarction1Thrombolysis1Acute Exacerbation of Chronic Obstructive Pulmonary Disease1Mechanical Power1

By trial register

Register	Trials	Recruiting
Clinical trials in China	36	23

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Sepsis

Sponsor	Trials
Children's Hospital of Fudan University	4
First Affiliated Hospital of Wannan Medical College	3
Zhujiang Hospital	3
Southeast University, China	2
Indian Council of Medical Research	1
Ningbo Medical Center Lihuili Hospital	1

Sponsors with the most current trials registered for this condition.

Questions about Beijing Chao Yang Hospital trials

How many clinical trials does Beijing Chao Yang Hospital sponsor?

Beijing Chao Yang Hospital is the lead sponsor of 36 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Beijing Chao Yang Hospital trials recruiting?

Yes. 23 of its 36 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Beijing Chao Yang Hospital testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Aspirin (1) and Heparin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Beijing Chao Yang Hospital clinical trials